Skip to Content

LAMISIL 250 (Lamisil 250 mg)

Generic Name: terbinafine

Pill with imprint LAMISIL 250 is White, Round and has been identified as Lamisil 250 mg. It is supplied by Novartis Pharmaceuticals.

Lamisil is used in the treatment of onychomycosis, toenail; cutaneous candidiasis; tinea capitis; onychomycosis, fingernail; tinea corporis and belongs to the drug class miscellaneous antifungals. There is no proven risk in humans during pregnancy. Lamisil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LAMISIL 250

Lamisil 250 mg LAMISIL 250 Front
Lamisil 250 mg LAMISIL 250 Back
Lamisil 250 mg LAMISIL 250
Lamisil 250 mg LAMISIL 250

Lamisil

Generic Name
terbinafine
Imprint
LAMISIL 250
Strength
250 mg
Color
White
Size
11.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Miscellaneous antifungals
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novartis Pharmaceuticals
Inactive Ingredients
silicon dioxide, hypromelloses, magnesium stearate, microcrystalline cellulose, sodium starch glycolate type A potato

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00078-0179 Novartis Pharmaceuticals Corporation
55289-0513 PDRX Pharmaceuticals Inc. (repackager)
54868-4008 Physicians Total Care Inc. (repackager)
49999-0466 Lake Erie Medical and Surgical Supply (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.